RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-13.65%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.62B
AUM Growth
+$2.62B
(-18%)
Cap. Flow
+$147M
Cap. Flow
% of AUM
5.6%
Top 10 Holdings %
Top 10 Hldgs %
51.83%
Holding
74
New
4
Increased
19
Reduced
26
Closed
3
Top Buys
Top Sells
| 1 |
argenx
ARGX
|
$49.3M |
| 2 |
UnitedHealth
UNH
|
$27.3M |
| 3 |
LivaNova
LIVN
|
$21.7M |
| 4 |
ICU Medical
ICUI
|
$21.6M |
| 5 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
$8.22M |
Sector Composition
| 1 | Healthcare | 96.11% |
| 2 | Consumer Staples | 2.55% |
| 3 | Industrials | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$120M
| $321M | 12.26% | 12,957,222 | – | – |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $238M | 9.09% | 22,158,891 -170,495 | -0.8% | -$1.83M |
|
|
SGEN
3
DELISTED
Seagen Inc. Common Stock
SGEN
| $151M | 5.77% | 854,013 +412,739 | +94% | +$73M |
|
|
4
argenx
ARGX
$43.6B
| $146M | 5.58% | 385,818 -130,125 | -25% | -$49.3M |
|
5
Krystal Biotech
KRYS
$4.27B
| $125M | 4.76% | 1,898,545 +82,847 | +5% | +$5.44M |
|
|
6
LivaNova
LIVN
$3.08B
| $101M | 3.87% | 1,623,762 -346,749 | -18% | -$21.7M |
|
|
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $72.8M | 2.78% | +913,319 | New | +$72.8M |
|
8
Beam Therapeutics
BEAM
$1.66B
| $71.6M | 2.73% | 1,849,887 +13,837 | +0.8% | +$536K |
|
9
The Beauty Health Co
SKIN
$264M
| $66.7M | 2.55% | 5,186,348 -118,157 | -2% | -$1.52M |
|
10
Replimune Group
REPL
$422M
| $63.7M | 2.43% | 3,645,309 -46,003 | -1% | -$804K |
|
|
IGMS
11
DELISTED
IGM Biosciences
IGMS
| $60.1M | 2.3% | 3,334,355 | – | – |
|
12
ADC Therapeutics
ADCT
$345M
| $59.7M | 2.28% | 7,512,029 +79,600 | +1% | +$633K |
|
13
Celldex Therapeutics
CLDX
$1.47B
| $55.8M | 2.13% | 2,070,288 +24,019 | +1% | +$648K |
|
14
Centene
CNC
$14.3B
| $55.1M | 2.1% | 651,447 +2,610 | +0.4% | +$221K |
|
15
Kymera Therapeutics
KYMR
$2.95B
| $51.3M | 1.96% | 2,607,130 -7,900 | -0.3% | -$156K |
|
16
Xenon Pharmaceuticals
XENE
$2.98B
| $49.9M | 1.9% | +1,639,344 | New | +$49.9M |
|
17
Regenxbio
RGNX
$451M
| $49.5M | 1.89% | 2,004,663 +27,740 | +1% | +$685K |
|
18
Atara Biotherapeutics
ATRA
$84.6M
| $48.6M | 1.86% | 6,242,756 -3,155 | -0.1% | -$24.6K |
|
|
IMGN
19
DELISTED
Immunogen Inc
IMGN
| $41.1M | 1.57% | 9,141,045 -76,900 | -0.8% | -$346K |
|
20
Elevance Health
ELV
$71.8B
| $40.5M | 1.55% | 83,987 +825 | +1% | +$398K |
|
|
SNCE
21
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $39.8M | 1.52% | 19,808,234 | – | – |
|
|
MDVL
22
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $38.5M | 1.47% | 25,192,751 +14,117,646 | +127% | +$21.6M |
|
23
Nurix Therapeutics
NRIX
$714M
| $38.1M | 1.45% | 3,006,684 -12,100 | -0.4% | -$153K |
|
24
Repare Therapeutics
RPTX
$71.7M
| $38.1M | 1.45% | 2,720,996 -12,000 | -0.4% | -$168K |
|
|
ONEM
25
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $35.5M | 1.35% | 4,521,825 +1,116,990 | +33% | +$8.76M |
|